Within a span of 5 years, the major achievements to the credit of the Torrent R&D Centre are the development of world class fermentation technology for Pen-G, synthesis of Omeprazole, Sparfloxacin, Nicorandil, Lamotrigine, Sertraline, Sildenafil Citrate, Repaglinide, Rosiglitazone, Clopidogrel, Sibutramine and Cerivastatin and the introduction of low dose combination of Lisinopril and Hydrochlorothiazide(Listril Plus/Forte), matching international quality standards. This rational combination was specifically formulated keeping in mind the needs of Indian patients.
First Time Introduction by the Centre
- Fluconazole 0.3% Eye Drops for the first time in the world.
- Esomeprazole (20,40mg) Multi Unit Particulate System (Pellets compressed in the form of tablet) for the first time in India.
- Rosiglitazoe 2mg/4mg Immediate Release + Metformin 500mg Sustanded - Release Dual Retard Technology launched in the form of Inlay Tablet for the first time of India.
- Few Non-Conventional Dosage Forms Developed
|Dilzem CD (Diltiazem)
||Controlled Release Pallets
|Alprax Plus (Alprazolam SR + Sertraline)
||Sustained Release + Immediate Release Bi Component Capsule
|Lamitor DT (Lamotrigine)
||Soft Gelatin Capsule
|Valparin Alkalets (Sodium Valproate)
||Enteric Coated Tablet
|Valparin Chrono (Sodium Valproate)
||Sustained Release Matrix Tablet
|Fegem (Iron Polymaltose Complex)
|Droxil Ready (Cefadroxil)
||Ready To Use Suspension
|Dilzem Inj (Diltiazem)
||Life Saving Injectable
|Nikoran IV (Nicorandil)
||Pellets compressed in Tablet
|Enselin MF (Rosiglitazone IR+ Metformin SR)
||Dual Retard Technology in form of Inlay Tablet